BioVie Statistics
NASDAQ: BIVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.40+0.1199 (+9.37%)
Market open · Delayed 15 min · as of Oct 9, 2:51 PM ET
BioVie by the numbers
BioVie has a market capitalization of $12.2 million based on 8.68M shares outstanding. With trailing EPS of $-3.05, BioVie is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.9% below its 50-day average and 7.6% below its 200-day average.
Average daily trading volume is 4.60M shares, or about $6.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BIVI valuation vs. peer median
| Metric | BIVI | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.15M | $11.29M | +8% |
| Avg. volume | 4.60M | 67.09K | +6760% |
Peer median across 8 companies: BLRX, KPRX, PHIO, GTBP, ASBP, LSTA, VTGN, GDTC.
Valuation
- Market cap
- $12.15M
- EPS (TTM)
- $-3.05
- Shares outstanding
- 8.68M
Price and trading
- Previous close
- 1.28
- Open
- 1.30
- Day range
- 1.28 – 1.40
- 52-week range
- 0.82 – 3.79
- 52-week change
- -35.03%
- Beta
- —
- Volume
- 163.51K
- Average volume
- 4.60M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 12.15M
- Forward Pe
- -2.46
- Eps
- -3.05
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.79
- Week52 Low
- 0.82
- Avg Volume
- 4.60M
- Shares Outstanding
- 8.68M
- Ma50
- 1.68
- Ma200
- 1.52
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -63.06%
- Pct From52w Low
- 70.72%